RAC1 and RAC1B in breast cancer therapy resistance have been studied recently, where RAC1 can contribute to chemotherapy resistance by altering metabolic pathways like the pentose phosphate pathway, and RAC1B has been shown to maintain stem cell populations that confer chemo-resistance [106,115]. The gene discussed is RAC1; the disease is breast carcinoma.